INOTEK PHARMACEUTICALS CORP RCKT 5.75 08.01.21
NOTE 5.750% 8/0 · US DOMESTIC · CUSIP 45780VAB8
9
institutional holders
$57.1mprincipal reported held*
$55.0mreported value*
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once ($8.0m this quarter). Holder counts are more reliable.
Holders, Q4 2019
| Manager | Shares | Change |
|---|---|---|
| DeepCurrents Investment Group LLC 0.91% of their portfolio | 18.1m $19.9m | — |
| CITADEL ADVISORS LLC 0.02% of their portfolio | 14.8m $16.7m | — |
| WOLVERINE ASSET MANAGEMENT LLC 0.15% of their portfolio | 7.5m $8.2m | — |
| Verition Fund Management LLC 0.25% of their portfolio | 7.3m $8.0m | — |
| DEUTSCHE BANK AG\ 0.00% of their portfolio | 4.0m $4.3m | — |
| CREDIT SUISSE AG/ 0.00% of their portfolio | 2.5m $2.7m | — |
| Bruce & Co., Inc. 0.43% of their portfolio | 2.0m $2.2m | — |
| Tetragon Partners GP Ltd 0.16% of their portfolio | 1.0m $1.1m | — |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | — |